"Serving families affected by autism and other neurodevelopmental disorders with expert diagnostics, evidence-based clinical care, groundbreaking research, and compassionate support."

During the past decade, University of Missouri, Thompson Center for Autism & Neurodevelopmental Disorders conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Missouri, Thompson Center for Autism & Neurodevelopmental Disorders" #1 sponsor was "Seaside Therapeutics, Inc." with 4 trials, followed by "University of Missouri-Columbia" with 3 trials sponsored, "MapLight Therapeutics" with 1 trials sponsored, "Stalicla SA" with 1 trials sponsored and "Yamo Pharmaceuticals LLC" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Missouri, Thompson Center for Autism & Neurodevelopmental Disorders" #1 collaborator was "United States Department of Defense" with 2 trials as a collaborator and "Autism Science Foundation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "University of Missouri, Thompson Center for Autism & Neurodevelopmental Disorders" are "Autism Spectrum Disorder" (5 trials), "Autism" (2 trials), "Autism Spectrum Disorders" (2 trials), "Fragile X Syndrome" (2 trials) and "Insomnia Chronic" (1 trials). Many other conditions were trialed in "University of Missouri, Thompson Center for Autism & Neurodevelopmental Disorders" in a lesser frequency.

Most popular intervention types in "University of Missouri, Thompson Center for Autism & Neurodevelopmental Disorders" are "Drug" (8 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Propranolol" (2 trials), "arbaclofen" (2 trials), "Arbaclofen" (1 trials) and "In-Person CBT for insomnia in children with autism" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Missouri, Thompson Center for Autism & Neurodevelopmental Disorders" are 10 trials for "All" genders.

Currently, there are NaN active trials in "University of Missouri, Thompson Center for Autism & Neurodevelopmental Disorders". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in University of Missouri, Thompson Center for Autism & Neurodevelopmental Disorders, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Missouri, Thompson Center for Autism & Neurodevelopmental Disorders, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".